Russia's second COVID-19 vaccine shows positive sign in early human trials: Report

second COVID-19 vaccine candidate developed by Russia is showing positive results in early trials in humans, according to reports. After approval of controversial 'Sputnik V' vaccine earlier this month, Russia is testing ar vaccine candidate dubbed 'EpiVacCorona'. As per reports, vaccine, which has been developed by country's Vector State Research Center of Virology and Biotechlogy, is showing positive signs following early testing in humans. Media reports suggest that all volunteers, who received vaccination, are feeling well as side effects have been observed in m so far. 

Re: EU, CureVac Conclude Talks For 225 Million COVID-19 Vaccine Doses

According to reports, 57 volunteers received vaccination in first phase of trials, while 43 received in placebo, meaning y were t given real vaccine but were convinced into thinking that y were given treatment in order to test wher effects produced by drug might be related to psychological processes. Media reports suggest that Russia will complete clinical trials of EpiVacCorona vaccine by September. According to reports, vaccine triggers an immune response after double iculation between 14-21 days, but so far only one patient has received drug twice.  

Re: Coronavirus Vaccine: Progress Going Well On Indigeus Candidates, Says Centre

Sputnik V

On August 11, Russia anunced that it h become first country to develop a vaccine and authorise it for public use, but experts from across world doubt safety of drug as it has t yet completed vanced trials on humans. World Health Organisation (WHO) said that Russia's vaccine is t part of list of nine candidates in vanced sts of testing because country h failed to provide sufficient evidence to global health body for it to make any judgement on drug. Russia on August 20 anunced that it will test Sputnik V on 40,000 people ding that it will be monitored by foreign research body. Russia h smartly named drug 'Sputnik V' after world's first artificial satellite launched by country during cold-war era in order to equate COVID-19 vaccine race to race between US and USSR. 

Re: WHO Says Russia's COVID-19 Vaccine Sputnik V Yet To Complete vanced Trials

Re: Russia To Test Its COVID-19 Vaccine 'Sputnik V' On 40,000 People Next Week